FIRAZYR Icatibant acetate

Similar documents
AIMOVIG solution for injection in pre-filled pen

AIMOVIG TM solution for injection in pre-filled pen erenumab Consumer Medicine Information

What Neulasta is used for

RELISTOR. Methylnaltrexone bromide, Subcutaneous solution for injection. Consumer Medicine Information

Before you take. Tell your doctor if you have any of the conditions mentioned below or if you have ever experienced any of these conditions.

TYPHIM Vi. Purified polysaccharide capsule of Salmonella typhi (Ty 2 strain) Consumer Medicine Information

DUKORAL. Oral inactivated cholera and ETEC vaccine. Consumer Medicine Information. It does not take the place of talking to your doctor or pharmacist.

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

APO-Olopatadine Eye Drops Contains the active ingredient olopatadine (as olopatadine hydrochloride)

Pemetrexed APOTEX Powder for Injection Contains the active ingredient pemetrexed (as disodium)

ADT Booster (ay-dee-tee boo-ster)

Neulasta pegfilgrastim (rbe) Consumer Medicine Information

APO-Ondansetron Contains the active ingredient, ondansetron (as hydrochloride dihydrate)

ZADITEN Eye Drops 1.0%

Normal Immunoglobulin (Human) 16%, solution for subcutaneous administration.

Perjeta Contains the active ingredient pertuzumab (rch)

Oxytocin APOTEX Solution for Injection Contains the active ingredient synthetic oxytocin

TEVAGRASTIM. What is in this leaflet. What TEVAGRASTIM is used for. filgrastim (rbe) Consumer Medicine Information. How it works

MERIEUX INACTIVATED RABIES VACCINE (MIRV) Rabies Vaccine

TEVAGRASTIM filgrastim (rbe)

Beclazone 50, 100, 250 micrograms CFC-Free Inhaler

Mycamine Micafungin (as sodium)

APO-Latanoprost Contains the active ingredient latanoprost

PHOLCODINE. Please follow the instructions on the packaging of the medicine you purchased and in this leaflet before you start using pholcodine.

Copaxone 40 mg/ml glatiramer acetate

Atrovent Metered Aerosol (CFC Free)

Copaxone 20 mg/ml glatiramer acetate

Influvac Inactivated influenza vaccine [surface antigen]

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

DALACIN C PHOSPHATE Injection Clindamycin phosphate

Package leaflet: Information for the user

Ceclor CD cefaclor monohydrate sustained release tablets

Contains the active ingredient levonorgestrel. For a copy of a large print leaflet, Ph:

28 November 2008 CMI for NEUPOGEN Page 1 of 8

Glatopa is prescription medicine used for the treatment of people with relapsing forms of multiple sclerosis (MS).

JANUVIA. What is in this leaflet. What JANUVIA is used for. Before you take JANUVIA. How JANUVIA works. When you must not take it

Valaciclovir generichealth Treatment of herpes simplex

Alvesco contains a medicine called ciclesonide, which belongs to a family of medicines called corticosteroids.

HEALTHCARE SUPPLIES SPECIALISTS. Product information. amaproducts.com.au HEALTHCARE SUPPLIES SPECIALISTS

APOHEALTH FAMCICLOVIR ONCE

MERIEUX INACTIVATED RABIES VACCINE (MIRV)

of LDL and HDL cholesterol.

belimumab (rmc) 120 mg and 400 mg powder Please read this leaflet carefully before you are given BENLYSTA.

If you have any concerns about taking this medicine, ask your doctor or pharmacist.

VIVAXIM Salmonella typhi Vi polysaccharide and inactivated hepatitis A virus antigen vaccine

CONSUMER MEDICINE INFORMATION

Colofac mebeverine hydrochloride

Otezla (apremilast) film coated tablets

Nivestim Filgrastim [rbe] (fil-gras-tim)

Beclazone CFC-Free Inhaler

Valaciclovir generichealth is used to prevent. infection and disease following solid organ transplantation.

Simplotan* tablets Tinidazole (tin-id-azole)

Before you use it. When you must not use it

How Entecavir GH Works

VIVAXIM. Salmonella typhi Vi polysaccharide and inactivated hepatitis A virus antigen vaccine. Consumer Medicine Information

Midazolam Injection Midazolam

Prolia Denosumab(rch) den''-os''-u''-mab Consumer Medicine Information (CMI)

ELAPRASE Idursulfase 6 mg/3 ml, Concentrate for Solution for Infusion

Persantin SR. What is in this leaflet. 200 mg capsules. Dipyridamole. Consumer Medicine Information

AUGMENTIN is also used to prevent infection from major surgery.

Bicillin L-A Benzathine benzylpenicillin tetrahydrate

EVOGAM. Information for patients Evogam NZ Patient Brochure Update FA3

ORENCIA (or-en-see-ah)

Ezetimibe Sandoz Ezetimibe 10 mg tablet

Chemists Own Strong Pain Extra Paracetamol and Codeine Phosphate

All medicines have risks and benefits. Your doctor has weighed the risks of you taking Triprim against the benefits he or she expects it will have.

REVESTIVE teduglutide Consumer Medicine Information

LISINOPRIL-GA tablets 2.5 mg, 5 mg, 10 mg, 20 mg. Lisinopril dihydrate

Human Normal Immunoglobulin 20% (20 g per 100 ml), solution for subcutaneous administration.

How it works. Use in children

Prolia Denosumab(rch) den''-os''-u''-mab Consumer Medicine Information (CMI)

OXIS TURBUHALER Formoterol fumarate dihydrate for inhalation

Duro-Tuss Dry Cough Liquid plus Nasal Decongestant Pholcodine (fol-co-dean); Pseudoephedrine hydrochloride (sue-doe-eff-eh-drine hydro-klor-ide)

PHENYLEPHRINE. Please read this leaflet and the label of the medicine you purchased, carefully before you start using Phenylephrine.

Aranesp darbepoetin alfa Consumer Medicine Information (CMI)

THYROGEN Thyrotropin alfa-rch, powder for injection

FUZEON enfuviride WHAT IS IN THIS LEAFLET BEFORE YOU USE FUZEON WHAT FUZEON IS USED FOR. When you must not use it. Use in children

Consumer Medicine Information TOPICIL. Please read this leaflet carefully before you start using Topicil Capsules.

Epilepsy is a condition where you have repeated seizures (fits). There are many different types of seizures, ranging from mild to severe.

Flecainide BNM. Please read this leaflet carefully before you start taking Flecainide BNM.

Aranesp darbepoetin alfa

This leaflet answers some common questions about HERCEPTIN SC. It does not contain all the available information.

Contains the active ingredient, famciclovir (fam-sye-kloveer) For a copy of a large print leaflet, Ph:

Cosudex. Bicalutamide 50 mg Tablets CONSUMER MEDICINE INFORMATION

If you have any concerns about using this medicine, ask your doctor or pharmacist.

INFORMATION FOR THE CONSUMER

All medicines have risks and benefits. Your doctor has weighed the possible risks of using SALOFALK against the expected benefits.

ALLMERCAP. Consumer Medicine Information (CMI) What is in this leaflet. What ALLMERCAP is used for. Before you take it

AUSTRAPEN ampicillin (as sodium)

oral solution (pronounced KEPP-ruh ) Contains the active ingredient levetiracetam (pronounced "LEE ve tye RA se tam")

HAVRIX 1440 and HAVRIX Junior

IMOJEV Japanese encephalitis vaccine (live, attenuated)

Before you use NovoThirteen. When NovoThirteen should not be used

BrinzoQuin Eye Drops 1.0%

Menomune. Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined. Consumer Medicine Information

If you have any concerns about taking this medicine, ask your doctor or pharmacist.

ORENCIA (or-en-see-ah)

LUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml)

Transcription:

Icatibant acetate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines, including have risks and benefits. Your doctor has weighed the risks of you having against the benefits they expect it will have for you. If you have any concerns about this medicine, ask your doctor, nurse or pharmacist. Keep this leaflet. You may need to read it again. What is used for is used for treating the symptoms of an acute attack of hereditary angioedema (HAE). During attacks of HAE, levels of a substance in your bloodstream called bradykinin are increased and this leads to symptoms like swelling, pain, nausea, and diarrhoea. How it works blocks the activity of bradykinin and therefore, helps reduce the symptoms of an HAE attack. Before you use When you must not be given it Do not use if you have an allergy (hypersensitivity) to icatibant, or any of the other ingredients listed at the end of this leaflet. Symptoms of an allergic reaction may include: shortness of breath, wheezing or difficulty breathing swelling of the face, lips, tongue or other parts of the body, skin rash, itching or hives. It is important to be able to tell when you might be having an allergic reaction as the symptoms are very similar to those of an attack of HAE, so you should discuss this with your doctor. If you are pregnant or plan on becoming pregnant, discuss this with your doctor before starting to use. If you are breast-feeding, you should not breast-feed for 12 hours after you have received. Do not give to a child under 18 years. The safety and effectiveness of in children under 18 years have not been established. Do not use after the expiry date printed on the pack. Do not use if the packaging is torn or shows signs of tampering. Do not use if there are any visible signs of deterioration, for example if the solution is cloudy, if it has floating particles, or if the solution is not colourless. If you are not sure whether you should use, talk to your doctor or pharmacist. Before you are given it Consult your doctor before using if you are suffering from angina (reduced blood flow to the heart muscle). Inform your doctor before using if you are taking a medicine known as an Angiotensin Converting Enzyme (ACE) inhibitor (for example: captopril, enalapril, ramipril, quinapril, lisinopril) which is used to lower your blood pressure or for any other reason. Consult your doctor before using if you have recently suffered a stroke. Tell your doctor if you have allergies to: Any other medicines Any other substances, such as foods, preservatives or dyes. Tell your doctor if you are pregnant or intend to become pregnant. Your doctor will discuss the possible risks and benefits of using during pregnancy. Tell your doctor if you are breastfeeding. You should not breastfeed for 12 hours after you have received. It is not known whether passes into your breast milk. Published by MIMS August 2015 1

Taking other medicines Tell your doctor or pharmacist if you are taking any other medicines, including any that you buy without a prescription from your pharmacy, supermarket or health food shop. can interact with other medicines e.g. ACE inhibitors (as previously discussed). Food and drink have no effect on the action of. How is used Injections are usually administered by healthcare professionals. If you wish to inject yourself and the doctor agrees it is appropriate (e.g. if you have a lot of HAE attacks or if you live far from a hospital or doctor), you will be trained on how to give yourself an injection. The following information is for patients who have been trained to inject themselves: As HAE attacks can often be serious, it is best to contact your doctor or hospital when you experience an attack. If the HAE attack involves your face, lips, throat, or voice box, or if you have any difficulty breathing, you should always contact your doctor or hospital. If your HAE attack has not shown signs of improvement within 2 hours of the injection of ; or if the attack spreads to your face, lips, throat, or voice box, or you develop any difficulty breathing, you should contact your doctor or hospital immediately. It is possible to have further injections of if you do not have relief from the HAE symptoms following the first injection; however, this should be done by your doctor or in hospital (see below) - or following the advice of your doctor. comes in a ready-to-use syringe. A needle is packed separately which you need to attach before use. is intended for subcutaneous injection (under the skin). is injected into the fatty tissue under the skin in the abdomen (tummy). Each syringe should only be used once. Please see step-by-step instructions for injecting at the end of this leaflet. How much and when it is given Your doctor will determine the exact dose of and will tell you how often it should be used. The recommended dose of is one injection (30 mg in 3 ml) given subcutaneously (under the skin) as soon as the symptoms of an attack of HAE (for example increased skin swelling, particularly affecting the face and neck, or increasing tummy pain) become troubling. If the HAE symptoms are still present, or return after initial relief, an additional injection of (3 ml) may be given after 6 hours. If after a further 6 hours you still experience symptoms you may need a third injection of (3 ml). You should have no more than 3 injections in a 24-hour period and no more than 8 injections in a month. After using Things you must do Tell your doctor immediately if you notice that your symptoms of the attack get worse after you received. Some of the side effects connected with are similar to the symptoms of your disease. If you use too much (Overdose) Immediately telephone your doctor or Poisons Information Centre (telephone 13 11 26), or go to Accident and Emergency at your nearest hospital if you think that an overdose has happened. Do this even if there are no signs of discomfort or poisoning. When high doses have been given, patients have experienced a drop in blood pressure. Things to be careful of Do not drive or operate any machinery if you feel tired or dizzy as a result of your HAE attack or after using. has minor to moderate influence on the ability to drive and operate machinery. Side effects Tell your doctor or pharmacist as soon as possible if you do not feel well after using. Like all medicines, can cause side effects, although not everybody gets them. Almost all patients receiving will experience a reaction at the site of the injection. The reaction may include burning sensations, reddening of the skin (erythema), pain, swelling, feeling of warmth, and itching (pruritus). These effects are usually mild and clear up by themselves without the need for any additional treatment. Ask your doctor or pharmacist to answer any questions you may have. Tell your doctor or pharmacist if you notice any of the following symptoms and they worry you: Published by MIMS August 2015 2

Nausea Pain in the abdomen (tummy) Weakness Dizziness Headache Blocked nose Rash Vomiting Fatigue Fever Sore throat Weight gain Asthma Cough Itching Redness of the skin Hot flushes Muscle spasm Hives These are the more common side effects of. Mostly, these are mild and short-lived. Other side effects not listed above may occur in some patients. Tell your doctor or pharmacist if you notice anything that is making you feel unwell. Do not be alarmed by this list of possible side effects as all medicines can cause side effects. You may not experience any of them. Storing Keep out of the reach and sight of children. Keep in the original pack until it is time for it to be used. Keep it below 25 C. Do not freeze. Medicines should not be disposed of via waste water or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment. Product description What it looks like is supplied in one single use pre-filled glass syringe with a grey plunger stopper. The solution is clear and colourless and free from visible particles. A hypodermic needle (25 G; 16 mm) is included in the package. Ingredients Active ingredient: Icatibant acetate (equivalent to 30 mg of icatibant) in 3 ml solution for injection in each pre-filled syringe. Other ingredients: Sodium chloride Acetic acid - glacial Sodium hydroxide Water for injections. The injection solution contains less than 1 mmol (23 milligrams) of sodium, so it is essentially 'sodiumfree'. does not contain lactose, sucrose, gluten, tartrazine or any other azo dyes. Name and address of Sponsor and supplier Shire Australia Pty Limited Level 6 123 Epping Road, North Ryde NSW 2113 Australia Freecall: 1800 012 612 AUST R number 160313 Date of preparation: November 2012 Registered trade mark of Shire Orphan Therapies GmbH, Germany Step-by-step instructions for injecting Step 1. Preparing your dose of Wash your hands with soap and water You will need the following items: - Your carton that includes 1 single-use prefilled syringe and 1 needle - An alcohol wipe - The medicine inside your prefilled syringe should be clear and colourless. Do not use your prefilled syringe if the solution contains particles, is cloudy, or an unusual colour. Step 2. Remove prefilled syringe and needle from the carton. Step 3. Remove the seal from the needle cap. (the needle should remain inside the protective needle cap until ready to use). See Figure B. Step 4. Hold the syringe firmly. Carefully attach the needle to the prefilled syringe containing the colourless solution. See Figure C. Published by MIMS August 2015 3

Step 11. Hold the syringe between a 45 to 90 degree angle to your skin with the needle facing the fold of skin you are holding. See Figure J. Step 5. Firmly screw the needle on the prefilled syringe. Be careful not to remove the needle from the needle cap. See Figure D. Step 8. Remove the needle from the needle cap by holding the needle cap and carefully pulling the syringe. Do not pull on the plunger. See Figure G. Step 12. Hold the fold of the skin. Bring the syringe to the skin and quickly insert the needle into the skin fold. See Figure K. Preparing the Injection Site Step 6. Choose the injection site. The injection site should be a fold of skin on your stomach, about 5 to 10 cm below your belly button on either side. See Figure E. Step 9. Hold the syringe in one hand, between your fingers and thumb. See Figure H. Step 13. Push the plunger, at the top of the syringe, over at least 30 seconds until no is in the syringe. See Figure L. The area you choose for injection should be at least 5 cm away from any scars. Do not choose an area that is bruised, swollen, or painful. Step 7. Clean your injection area with an alcohol wipe and allow it to dry. See Figure F. Step 10. Use your other hand to gently pinch the fold of skin you cleaned with the alcohol wipe between your thumb and fingers for your injections. See Figure I. Step 14. Release the skin fold and gently pull the needle out. See Figure M. Published by MIMS August 2015 4

Step 15. Place the used syringe with the needle attached in a sharps container which is made of hard materials and is sealable (such as biohazard container). Seal the container and throw it away the right way. There may be state and local laws about the right way to throw away used syringes and needles. Ask your healthcare providers or pharmacist how to throw away used syringes and needles. See Figure N. Published by MIMS August 2015 5